ArticleClinical, cosmetic and investigational dermatology2026
Preclinical Evaluation of Anti-Acne Topical Creams Containing Psorospermum Febrifugum Stem Bark Extract: Lipase Inhibition, Sebum Regulation, and Dermal Safety.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acne vulgaris is a multifactorial inflammatory disorder of the pilosebaceous unit characterised by excessive sebum production, follicular hyperkeratinisation, microbial dysbiosis, and inflammatory activation. Limitations of conventional therapies, including irritation and antimicrobial resistance, have increased interest in plant-derived topical agents offering multi-target efficacy with improved tolerability. Aim: To formulate standardised topical creams containing Methods: Botanically authenticated stem bark was extracted by cold maceration using 70% ethanol. A dichloromethane (DCM) fraction was prepared and analysed by TLC-GC-MS. Oil-in-water creams (1-5% w/w extract) were developed and evaluated for stability. In vitro anti-acne activity was assessed using a fluorometric lipase inhibition assay employing porcine pancreatic lipase as a validated surrogate model for acne-associated lipolytic activity. Sebum-regulating efficacy was evaluated in an oleic acid-induced seborrhoea rat model following topical application for 14 days. Dermal tolerability was assessed per OECD Guideline 404. Results: Extraction yield was 15.1 ± 0.1% w/w. Phytochemical analysis revealed substantial phenolics (162.3 ± 5.1 mg GAE/g), flavonoids (124.5 ± 3.8 mg QE/g), and terpenoids (211.9 ± 6.2 mg/g). TLC-GC-MS identified 42 compounds across three bands, predominantly fatty acids and derivatives. Extract-loaded creams demonstrated significant, concentration-dependent lipase inhibition (p < 0.001), with the highest concentration achieving 57% inhibition. The formulations significantly reduced oleic acid-induced sebum production in a dose- and time-dependent manner (p < 0.001), with a strong positive correlation between lipase inhibition and sebum reduction (r = 0.88, p < 0.01). All formulations were classified as non-irritant. Conclusion: Standardised
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.